Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page revision was bumped from v3.5.2 to v3.5.3, indicating a new version of the page content has been published. This reflects maintenance or minor behind-the-scenes updates to the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe page's revision badge was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision label updated to v3.4.3 in the page footer, replacing the previous v3.4.2.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 removed, reflecting a maintenance update on the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedA general site notice about a lapse in government funding and NIH operating status was added, directing users to cc.nih.gov and opm.gov for updates. The site revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.